Winter storm warnings continue in northern Minnesota 

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

A panel of experts voted unanimously to recommend that the Food and Drug Administration authorize a booster dose of the Johnson & Johnson COVID-19 vaccine.

In a 19-0 vote, the panel recommended that the booster dose come at least two months after initial immunization with one shot of the J&J vaccine. It applies to people 18 years and older. 

During the meeting, J&J presented data that showed the protection of the single shot remained largely stable over time but that a second dose pushed protection to a higher level.

Dr. Peter Marks, director of FDA's Center for Biologics Evaluation and Research, said the morning's presentations by J&J didn't include other relevant information about why a booster might be valuable after the initial immunization. "There are data suggesting the effectiveness of the vaccine is actually less robust than the company's presentation here," he said. 

Marks then called on Dr. Amanda Cohn, a panelist who is also chief medical officer of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention. She cited a 

 that showed the J&J vaccine had effectiveness of around 68 percent in keeping people out of the hospital for COVID-19 compared with more than 90 percent for Moderna's vaccine and about 77 percent for the Pfizer-BioNTech after about four months. 

Cohn said the J&J vaccine's protection was substantially lower than the mRNA vaccines made by Moderna and Pfizer — even when waning of their protection is taken into account. 

"I think, frankly, this was always a two-dose vaccine," said Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, said during the panel discussion before the vote. 

The FDA isn't bound to follow the advisory panel's recommendation, but it usually does. 

Health

COVID-19

Scott Hensley

Author

A panel of experts voted to recommend that the Food and Drug Administration authorize a booster dose of the Johnson & Johnson COVID vaccine at least two months after the first shot.

An FDA panel of experts backs J&J COVID vaccine booster

Go Deeper.

Like this?

News you can use in your inbox